Sedulo

MARCH 15, 2023

As leaders in competitive strategy consulting, serving the life sciences community for the last 17 years, Sedulo Group can help you: Build a comprehensive view of the current and future competitive landscape. Obtain details on competitor clinical trial locations. Assess and benchmark enrollment timing.

Biotech 52

Biotech Competitive Landscape Pharmaceutical Benchmarking 52

Alpha Sense BI

APRIL 29, 2024

Below, we explore the trends and themes shaping the venture capital landscape in 2024, and the ways investors can strategically position themselves for success. Instead, investors will likely turn to innovative start-up companies with promising growth plans and strong leadership teams.

Capital 52

Capital Due Diligence Biotech Startups 52

Evalueserve

DECEMBER 6, 2021

Within the healthcare industry, healthcare equipment continues to outperform (refer to the graph below) driven by the urgent need for innovative care delivery in new or alternative settings and expedited recovery of demand especially for elective procedures. Sponsor deals rebounded exceptionally.

Capital 98

Capital Globalization Biotech Marketing 98

Alpha Sense BI

MAY 5, 2023

2023 so far has revealed ideal conditions for dealmaking due to valuation resets, lessened competition for deals, and new assets coming to market. M&A Trends by Industry Healthcare The COVID-19 pandemic ushered in a wave of unprecedented innovation, progress, and transformation to the healthcare industry in 2020.

Biotech 97

Biotech Capital Banking Startups 97

Alpha Sense BI

APRIL 19, 2024

2020 and 2021 were marked by increased innovation, accelerated growth, and workforce expansion. As we navigate 2024, the landscape appears positioned for a triumphant comeback. Inflationary pressures are forecasted to ease and new innovations are capturing the attention of consumers, investors, and executives across various industries.

Technology 69

Technology Technology Retail Biotech 69